Recent advances in vaccines and therapeutics for Nipah virus

The Nipah virus (NiV) is a newly discovered zoonotic paramyxovirus that affects people and causes serious, frequently fatal respiratory and neurological conditions. Following an encephalitis outbreak among pig farmers in Malaysia and Singapore, the virus was initially identified, and subsequent outbreaks in Bangladesh or India took place virtually annually. Due to NiV’s high pathogenicity, the pandemic potential spread, and lack of licensed vaccines or therapeutics, research and development is needed to create highly sensitive and precise diagnostic tools, antivirals, and vaccines that will aid in preventing and controlling outbreak situations in the future.